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Abstract
A class of linear and four-arm mannosylated brush copolymers based on poly(ethylene glycol) and poly(ε-caprolactone) is
presented here. The synthesis through ring-opening and atom transfer radical polymerizations provided high control over molecu-
lar weight and functionality. A post-polymerization azide–alkyne cycloaddition allowed for the formation of glycopolymers with
different mannose valencies (1, 2, 4, and 8). In aqueous media, these macromolecules formed nanoparticles that were able to bind
lectins, as investigated by concanavalin A binding assay. The results indicate that carbohydrate–lectin interactions can be tuned by
the macromolecular architecture and functionality, hence the importance of these macromolecular properties in the design of
targeted anti-pathogenic nanomaterials.
Introduction
Carbohydrate–protein interactions are involved in many biolog-
ical processes, including cell recognition and cell–cell adhesion.
These interactions drive pathological events, such as cellular
infections by viruses (e.g., HIV and Ebola [1,2]) and toxins
(e.g., Shiga and Cholera toxins [3]). Carbohydrate–protein
interactions in biological systems are mostly multivalent, which
allows one to enhance their strength with respect to the weak
single saccharide–protein connections. Carbohydrate-binding
proteins are known as lectins. A way to interfere with patholog-
ical carbohydrate–protein interactions is the use of artificial
ligands able to antagonize lectins, possibly with higher affinity
than the natural ligands. Multivalent glycoconjugates have been
recently synthesized with the aim of producing powerful anti-
pathogenic agents [4]. The so called “cluster glycoside effect”
is the enhanced activity of a multivalent glycoderivative with
respect to the monovalent saccharide [5].
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Glycopolymers, i.e., polymers presenting pendant saccharides,
are an important and well-studied class of synthetic glycoclus-
ters [6]. They have the advantage of being easy to synthesize
and present larger valencies with respect to other multivalent
compounds, thus exhibiting an amplified binding potency
towards lectins. In some cases, glycopolymers have shown
affinities for lectins that are comparable to those of antigens and
antibodies [7]. Nevertheless, polymers often lack homogeneity;
they can be highly polydisperse and poorly characterized, and
this represents a clear limitation for therapeutic applications,
since different molecular weight, architecture and functionality
can influence the macromolecule bioactivity [8]. Controlled
radical polymerization (CRP) techniques, such as atom transfer
radical polymerization (ATRP), reversible addition fragmenta-
tion chain transfer (RAFT) polymerization, single-electron
transfer living radical polymerization (SET-LRP) and nitroxide-
mediated radical polymerization (NMP), are often used to
produce well-defined glycopolymers with controlled molecular
weight and narrow molecular weight distribution [9,10]. In par-
ticular, ATRP is a living radical polymerization catalyzed by a
transition metal, normally copper or ruthenium, and initiated by
halogenated compounds, typically alkyl halides. ATRP is
tolerant of a large range of functional groups; the use of multi-
functional initiators allows for the synthesis of materials with
different topologies, e.g., comb-like and star polymers [11].
ATRP of an unprotected carbohydrate-functionalized monomer,
starting from a four-arm initiator based on poly(ε-caprolactone),
led to a library of glucose-functionalized aggregates able to
bind the glucose- and mannose-binding lectin Concanavalin A
(Con A) [12]. The combination of ATRP of protected alkyne
monomers and a copper-catalyzed azide–alkyne click cycload-
dition (CuAAC) with azide-bearing sugars was reported as an
effective strategy to prepare multivalent mannose- and galac-
tose-pendant polymers. Their interaction with Con A strictly
depended on the mannose epitope density: fully mannosylated
polymers were more active than the corresponding partially
galactose-functionalized molecules [13]. Analogous copoly-
mers were tested as ligands for DC-SIGN, a tetravalent lectin
involved in the early stage of HIV infection [1]. Also in this
case, molecules presenting the highest mannose density had the
highest activity towards the lectin [14]. A class of five-arm and
eight-arm glycopolymers bound to DC-SIGN with picomolar
affinities, one order of magnitude more than the corresponding
linear molecules. The authors speculated that this may occur
because of the ability of star-shaped polymers to bind simulta-
neously the four lectin carbohydrate-recognition domains [15].
DC-SIGN was efficiently targeted also by mannose-decorated
polymers synthesized through SET-LRP of glycomonomers
[16]. When amphiphilic glycopolymers were produced, they
formed nanoparticles in aqueous solution, and their binding ac-
tivities were also affected by shape and size [17]. In addition,
the high surface area of spherical self-assembled structures can
confer glycopolymers a high affinity towards lectins [18].
Among different synthetic macromolecules used in biomedical
applications, copolymers based on poly(ethylene glycol) (PEG)
and poly(ε-caprolactone) (PCL) are found in many FDA-ap-
proved products [19]. PCL repeating units are constituted by
five non-polar methylene groups and one labile ester group. It
was reported that biodegradability and performance of PCL in
cell culture studies are enhanced when it is modified with PEG
[20]. PEG is a hydrophilic nontoxic polymer that does not
promote immune responses. Pegylation reduces the nonspecific
binding of nanoparticles to blood proteins and macrophages,
making them non-immunogenic and non-antigenic [21].
PEG-PCL copolymers are amphihilic materials that can sponta-
neously assemble in aqueous media, forming colloidal aggre-
gates (e.g., micelles and vesicles) above their critical aggrega-
tion concentration (CAC). The resulting self-assembled
nanoparticles can act as drug carriers and delivery systems,
being able to accommodate a hydrophobic drug within their
hydrophobic core [22], or chemically bind bioactive agents
[23,24].
In this work, we used ATRP to produce a library of brush
copolymers, which were synthesized via random copolymerisa-
tion of PEG- and PCL-based macromonomers. Their polymeric
backbones were then mannosylated through a post-polymeriza-
tion CuAAC, in order to obtain potential lectin ligands. Copoly-
mers of different shapes were synthesized, i.e., linear or four-
arm, according to the initiator used for the ATRP. The percent-
age of PCL blocks bearing a triple bond with respect to the PEG
blocks was varied. Different clickable polymeric backbones
were produced and finally mannosylated, obtaining different
overall mannose valencies (1, 2, 4, and 8). The structures,
acronyms and valencies of the synthesized comb-like-
glycopolymers are reported in Figure 1. The final glycopoly-
mers have a flexible structure that should confer them the possi-
bility to freely adjust the position of the mannose residues,
matching the one of the lectin binding sites. Their capability to
effectively expose mannose and behave as lectin ligands was in-
vestigated using Concanavalin A as a model lectin. Moreover,
the glycopolymers are amphiphilic materials, and their ability to
spontaneously self-assemble in nano-sized-aggregates was also
examined.
Results and Discussion
Synthesis of the PCL-based macromonomer
Propargyl-poly(ε-caprolactone)-methacrylate (Pg-PCL-MA)
was prepared in two steps starting from ε-caprolactone, through
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Figure 1: Synthetic approach (upper panel), final structure and nomenclature (lower panels) of the mannose-functionalized PEG-PCL copolymers.
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Scheme 1: Synthetic pathway to obtain linear and four-arm mannosylated copolymers.
a bulk ROP initiated by propargyl alcohol and catalyzed by
tin(II) 2-ethylhexanoate [25] (Scheme 1, step a), targeting a
degree of polymerization (DP) equal to 5. Reaction conver-
sions were monitored by means of 1H NMR analysis; almost
full monomer conversion (99%) was obtained after 6 h. The
dispersity of the purified polymer was 1.19. Subsequent
methacrylation of the terminal hydroxy group was accom-
plished in high conversions (≥95%) using freshly distilled
methacryloyl chloride, in order to remove cyclic reactive impu-
rities [26] (Scheme 1, step b).
Synthesis of the clickable alkyne polymers
(A4-)PEGx-PCLy
Polymeric backbones with the general formula (A4-)PEGx-
PCLy were synthesized through ATRP, randomly copolymer-
izing different percentages of commercially available poly-
(ethylene glycol)methyl ether methacrylate (PEG-MA, average
Mn = 500 Da, with 8 or 9 ethylene oxide repeating units) and
propargyl-poly(ε-caprolactone)-methacrylate (Pg-PCL-MA) in
the presence of Cu(I)Br/1,1,4,7,10,10-hexamethyltriethylenete-
tramine (HMTETA) catalyst [27]. Ethyl α-bromoisobutyrate (1)
Beilstein J. Nanotechnol. 2019, 10, 2192–2206.
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Figure 2: A) Kinetic profiles obtained for the synthesis of (A4-)PEG9-PCL1 and (A4-)PEG8-PCL2 copolymers. Reactions were conducted using
CuBr/HMTETA as catalytic system, at 50 °C under nitrogen atmosphere. B) GPC chromatograms of PEG9-PCL1 and A4-PEG9-PCL1.
Table 1: Summary of properties of the copolymers obtained by ATRP. PEG/PCL macromonomers molar ratio, conversion, number average molecu-
lar weight obtained by 1H NMR (Mn,NMR) and GPC (Mn,GPC), and dispersity Ð (by GPC) are listed in the table.
polymer PEG/PCL
[mol/mol]
conversion
(%)
Mn,NMR
[g/mol]
Mn,GPC
[g/mol]
Ð
PEG9-PCL1 9/1 95 5040 6090 1.24
PEG8-PCL2 8/2 91 4990 6301 1.06
PEG7-PCL3 7/3 58 3425 — —
A4-PEG9-PCL1 9/1 98 20780 9640 1.11
A4-PEG8-PCL2 8/2 87 18760 11340 1.06
and pentaerythritol tetrakis(2-bromoisobutyrate) (2) were
chosen as the initiators for linear and four-arm polymers, re-
spectively (Scheme 1, step c).
A DP value of 10 (for the linear polymers and for each branch
of the four-arm ones) was targeted, in order to obtain macro-
molecules of different valencies, while maintaining relatively
short and flexible polymer chains, which minimize steric
hindrance during lectin binding. Different percentages of PEG
and PCL macromonomers were used, since the number of PCL
side chains defined the final number of pendant mannose, as
well as the self-assembly behavior in water. Remarkably, when
the ratios PEG/PCL were 9:1 or 8:2, the polymerizations
achieved high conversions (≥87% after 6 h), as calculated from
1H NMR spectroscopy results (see Figure S2, Supporting Infor-
mation File 1). The semilogarithmic kinetic plots revealed first-
order kinetics (Figure 2A), demonstrating a good reaction
control over the polymer molecular weight and the molecular
weight distribution, which was also confirmed by dispersity Ð
values lower than 1.24 (Figure 2B, Table 1). The deviation of
the number average molecular weight calculated by 1H NMR
from the value obtained by GPC (which was substantial for the
four-arm polymers) was likely to be caused by the polystyrene
calibration and by the intrinsic limitation of the GPC to deter-
mine the exact molecular weight of comb-like and hyper-
branched polymers, as observed in numerous earlier publica-
tions [28].
Increasing the percentage of PCL to PEG/PCL = 7:3, the reac-
tions stopped at a conversion of around 58% (Table 1 and
Figure S3, Supporting Information File 1). It is known that
copper-catalyzed ATRP can be complicated by the presence of
monomers bearing triple bonds, which can indeed coordinate
the copper species. Moreover, also the acetylene group can be
subjected to radical addition and subsequent polymerization and
cross-linking [29]. For this reason, polymerizations using PCL
monomers bearing protected triple bonds were also performed
[30]. However, no improvements were obtained even by using
trimethylsilyl-protected-Pg-PCL-MA, the homopolymerization
of which achieved a conversion of 55% (see Supporting Infor-
mation File 1), comparable to the homopolymerization of
Pg-PCL-MA (43%). The use of a more active catalytic system
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such as N ,N ,N ′ ,N ′ ′ ,N ′ ′-pentamethyldiethylenetriamine
(PMDETA) [31] did not improve the outcome of the reaction.
The characterisation of the copolymer with a PEG/PCL ratio of
7:3 was therefore abandoned, and further study was focused on
the copolymers with higher PEG/PCL ratios. The copolymeri-
zation of PEG-MA and TMS-Pg-PCL-MA in an 8:2 ratio cata-
lyzed by CuBr/PMDETA achieved almost full conversions, but
the kinetic was not linear (Figure S10, Supporting Information
File 1), whilst the analogous reaction with a PEG-MA/Pg-
PCL-MA ratio of 8:2 stopped at a conversion value of 65%.
Final products were purified through filtration over a neutral
alumina pad to remove the copper catalyst, followed by precipi-
tation in diethyl ether.
Synthesis of the mannosylated polymers
The sugar functionalization of the polymeric backbone was per-
formed through CuAAC click reaction (Scheme 1, step d), by
combining the triple bonds with 2-azidoethyl α-ᴅ-mannopyran-
oside (3), synthesized as already reported [32] (see Supporting
Information File 1, Figure S1).The reaction conditions for the
CuAAC were chosen according to [33]. In particular, the cata-
lytic copper species was produced in situ by reducing copper(II)
sulfate pentahydrate with sodium ascorbate, in the presence of
tris[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl]amine (TBTA) as
copper(I)-stabilizing ligand. Both the actual PCL percentage
and the molecular weight of the reacting polymers were calcu-
lated according to 1H NMR analysis. An excess of 1.5 equiv of
azide-bearing mannose 3 with respect to each triple bond was
used. 2-azidoethyl α-ᴅ-mannopyranoside consumption was
assessed through thin layer chromatography (TLC), whilst the
triple bond conversion was monitored by means of 1H NMR
analysis. The disappearance of the alkyne proton peak
(3.0 ppm) and the appearance of a signal for the C=C–H proton
of triazole (8.1 ppm) were observed (Figure 3). The shift of the
peak corresponding to the methylene group near the triple bond
(4.5 ppm) and the appearance of the signal of mannose
anomeric protons (Man-H1, 4.7 ppm) in the product spectrum
also confirmed the functionalization.
Reactions were completed after three days. The crudes were
purified by dialysis against water, and the final products
(A4-)PEGx-PCLy-Many were lyophilized, achieving moderate
to high yields.
Nanoparticle formation and size
characterization
Dynamic light scattering (DLS) was used to determine the
hydrodynamic diameter (Dh) of the polymers and their glyco-
derivatives, once dispersed in aqueous solution. Firstly, the non-
mannosylated polymers were tested in three different media
(H2O, 10 mM PBS, 0.9% w/v NaCl) and at three different tem-
peratures (10, 25 and 37 °C; concentration of 1 mg/mL, see
Supporting Information File 1, Figures S11–S22, Tables
S1–S4). In any medium, polymers formed nanoparticles with
Dh varying from 7.5 to 11.3 nm, a size range which corre-
sponds to 99–100% of the volume distribution. The remaining
0–1% was due to the presence of aggregates with a size of
hundreds of nanometers as revealed by the scattering intensity
distributions (Supporting Information File 1). Because of
the limitation of the CONTIN algorithm used by this DLS anal-
ysis to determine a bimodal distribution of particle sizes
[34], the predominance of small nanoparticles was confirmed
by transmission electron microscopy (TEM) imaging
(Figure 4), where dehydrated flattened particles of small size
(10–20 nm) are shown together with few larger particles
(50–100 nm).
Comparing the results obtained at the three different tempera-
tures, it was observed that these polymers were not thermore-
sponsive, although PEG-copolymers may generally present a
lower critical solubility temperature (Tables S1–S4) [35]. For
our purposes, this could be an advantage, since they maintain
the same size under different operation conditions: storage,
room and body temperature.
Also the DLS distributions of the mannosylated (A4-)PEGx-
PCLy-Many glycopolymers in aqueous media (water and HBS
buffer) were characterized by two populations. The volume dis-
tribution was still dominated by small-size nanomaterials
(Dh ≈ 10 nm, Figure 5), although their intensity generally de-
creased with respect to larger colloids (Table 2 and Supporting
Information File 1, Figures S23 and S24). This tendency may
be due to the presence of the mannose residues that, being
connected to the hydrophobic PCL chains, could affect the self-
assembly of the macromolecules and generate some aggregates.
Remarkably, four-arm species had a slightly lower Dh than the
corresponding linear species.
Turbidity assay
The ability of glycopolymers to bind lectins was assessed using
Concanavalin A (Con A), a model lectin able to recognize α-ᴅ-
mannosyl and β-ᴅ-glucosyl residues. At physiological
pH values, Con A is a tetramer, composed by four 26 kDa
monomeric units, each of them possessing one coordination site
[36,37]. When multivalent carbohydrate compounds bridge
multiple Con A tetramers, insoluble clusters are formed, turning
the originally transparent solution turbid (Figure 6B). Each
single macromolecule may interact with many Con A receptors,
although steric effects prevent binding of every mannose
residue [38] (Figure 6A). Glycopolymers were tested in the
presence of Con A in HBS buffer at pH 7.4. A fixed mannose
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Figure 3: Comparison of the 1H NMR spectrum of one selected polymer (A4-PEG8-PCL2, MeOD) before (upper panel) and after (lower panel) the
mannosylation reaction. The disappearance of the peak of the alkyne proton (A, upper) and the appearance of the peak of the triazole (9, lower),
together with the presence of the Man-H1 proton (1, lower) in the product demonstrate the formation of the mannosylated polymer (A4-PEG8-PCL2-
Man2).
concentration 2.5 times higher than the Con A binding site con-
centration was used, and turbidity was measured using an
UV–vis spectrometer (Figure 7). The kinetics of glycopolymer-
induced clustering were also investigated. In particular, the
initial rates of Con A clustering, expressed as arbitrary units
per minute (k, AU/min), were derived from the initial slope
Beilstein J. Nanotechnol. 2019, 10, 2192–2206.
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Figure 4: TEM images of A4-PEG8-PCL2 10 mg/mL in water; size distribution is dominated by small nanoparticles (diameter ≤ 20 nm).
Figure 5: DLS size distribution (vol %) of the glycopolymers PEG9-PCL1-Man1 (A), PEG8-PCL2-Man2 (B), A4-PEG9-PCL1-Man1 (C), A4-PEG8-
PCL2-Man2 (D), tested in water (1 mg/mL) at 25 °C.
Table 2: DLS analyses of polymers and corresponding glycopolymers in water (1 mg/mL) at 25 °C.
general formula valency hydrodynamic radius (nm) (intensity (%))
polymer glyco derivative
PEG9-PCL1-(Man1) 1 8.5 (73) 8.6 (83)
PEG8-PCL2-(Man2) 2 10.2 (73) 10.8 (6)
A4-PEG1-PCL1-(Man1) 4 8.1 (79) 5.8 (12)
A4-PEG8-PCL2-(Man2) 8 9.6 (63) 8.0 (10)
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Figure 6: A) Schematic representation of Con A clustering by multivalent ligands. B) Con A suspensions after interaction with (a) PEG8-PCL2-Man2
(turbid), (b) A4-PEG8-PCL2-Man2 (turbid), (c) PEG9-PCL1-Man1 (transparent) and (d) A4-PEG9-PCL1-Man1 (turbid).
Figure 7: Turbidimetric assay results. A) Optical density (OD) data were recorded at 420 nm every 12 s for 10 min. B) t1/2 was calculated as the time
to reach half (OD= 0.5 a.u.) of the maximum optical density in normalized OD curve. The initial slope of the OD curve was used to determine the initial
aggregation rate k. C) k (AU/min) and t1/2 plotted as function of mannose valency.
of the curves; the time to reach half of the maximum turbidity
(t1/2) was determined from the endpoint of precipitation
(Table 3).
The curves of the optical density (OD) measured as a function
of the time (Figure 7) confirmed that polymers without
mannose residues (A4-PEG8-PCL2) and mannose itself were
Beilstein J. Nanotechnol. 2019, 10, 2192–2206.
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Table 3: Initial rates of Con A precipitation (k, AU/min) and time to reach half of the maximum turbidity (t1/2, s) in turbidity assays.
Glycopolymer Valency k (AU/min) t1/2 (s)
PEG9-PCL1-Man1 1 — —
PEG8-PCL2-Man2 2 0.75 10
A4-PEG9-PCL1-Man1 4 0.41 15
A4-PEG8-PCL2-Man2 8 0.32 29
not able to induce Con A clustering. In contrast, PEG8-PCL2-
Man2, A4-PEG8-PCL2-Man2 and A4-PEG9-PCL1-Man1
were able to bind Con A in a multivalent fashion, leading to an
increase of turbidity. Interestingly, turbidity was not observed
with the monovalent compound PEG9-PCL1-Man1, suggesting
that the polymer and the resulting nanosized colloid in water do
not have a suitable valency for the formation of Con A clusters.
We assumed that the mannose residues were not hidden within
the polymer colloids but were exposed for binding, since all the
other glycopolymers did precipitate the lectin. The divalent
compound PEG8-PCL2-Man2 was the most efficient aggluti-
nating agent of the series, even more potent than the octa- and
tetra-valent polymers. In the case of the divalent compound
PEG8-PCL2-Man2, the absorbance quickly reached a plateau
and then remained almost constant, although a stepwise varia-
tion of the OD indicated a partial precipitation of the aggre-
gates, as shown in Figure 6B. The same happened for the
octavalent glycopolymer A4-PEG8-PCL2-Man2, but with a
much lower initial rate. This behavior was already reported in
the literature and it was ascribed to the slower Con A precipita-
tion and the formation of cross-linked complexes over time
[12,38,39]. Regarding the four-arm macromolecules, the
tetravalent A4-PEG9-PCL1-Man1 showed a similar behavior
as A4-PEG8-PCL2-Man2, but it reached a much lower plateau,
which indicated the formation of smaller colloidal clusters
when the valency was reduced from 8 to 4. Moreover, the
octavalent compound seemed to bound Con A more slowly
(k-octa = 0.32 AU/min vs k-tetra = 0.41 AU/min, Table 3). This
result may be ascribed to an effect of the different polymer
composition on the aggregation kinetics. As general trend, the
rate constant k of Con A clustering decreased as the valency in-
creased, and consequently the time to reach half of the
maximum turbidity t1/2 increased as the valency increased
(Table 3 and Figure 7C).
According to these results, it seemed that the Con A clustering
activity of these macromolecules depended not only on their
valency, but also on their molecular weight and architecture
[40]. For example, the best result obtained for the divalent
polymer, which has a lower mannose density, may depend on
its lower steric hindrance, which results in a more efficient
Con A binding.
Conclusion
A series of amphiphilic polymers, with linear or four-arm struc-
ture and consisting of a random sequence of PEG and PCL
blocks, was successfully synthesized via a combination of ROP
and ATRP. Polymers were subsequently mannosylated through
a CuAAC click reaction, obtaining final glycopolymers with a
mannose valency of 1, 2, 4 or 8. This synthetic strategy was
exploited to produce well-defined nanomaterials that self-
assemble in aqueous media forming ultrasmall nanoparticles.
The ability of these glyco-functionalized nanoparticles to effi-
ciently expose mannose to lectins was investigated with the
model Concanavalin A, through turbidity assays. While the
monovalent macromolecule was not able to induce Con A clus-
tering, the linear divalent glycopolymer had a binding kinetics
faster than the other four-arm compounds, and tetravalent one
was even more active than the octavalent. These results indicat-
ed that besides mannose valency, macromolecular architecture
can deeply influence the capability to bind lectins. According to
their tunable characteristics, these glycopolymers can be poten-
tially utilized as targeted anti-pathogenic nanomaterials and as
well as for cell-targeted drug delivery.
Experimental
General procedures
Chemicals were purchased by commercial sources and used
without further purification, unless otherwise indicated. Poly-
ethylene glycol methyl ether (Mn = 500 Da) was purchased
from Sigma-Aldrich. 2-Azidoethyl α-ᴅ-mannopyranoside (3)
was synthesized as already described [32]. When anhydrous and
oxygen-free conditions were required, the reactions were per-
formed under nitrogen atmosphere. Inhibitor-free THF used for
ATRP reactions was degassed prior use; THF used for click
reaction was dried over Na/benzophenone and freshly distilled.
Thin-layer chromatography (TLC) was performed on Silica Gel
60 F254 plates (Merck) with UV detection (254 and 365 nm) or
using appropriate developing solutions. Flash column chroma-
tography was performed on silica gel 230–400 mesh (Merck).
Automated flash chromatography was performed on a Biotage®
Isolera™ Prime system. NMR experiments were recorded on a
Bruker AVANCE 400 MHz instrument at 298 K. Chemical
shifts (δ) are reported in ppm downfield from the deuterated
solvent as internal standard, coupling constants (J) in Hz. The
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1H NMR resonances of compounds were assigned with the
assistance of COSY and HSQC experiments. HSQC experi-
ments were also used to assign the chemical shift of protons
overlapping with the solvent signals. Signals were abbreviated
as s, singlet; bs, broad singlet; d, doublet; t, triplet; q, quartet;
m, multiplet. Sugar protons were numbered as customary. GPC
analyses were carried out with Jasco instrument and following
set up: 2055i auto sampler; RI-2031 refractive index detector;
CO-2060 plus oven column; PU-2080 pump; three PLgel
300 mm∙7.5 mm (5 μm particle size) (10E4, 10E5, 500 A) and a
PLgel 50 mm∙7.5 mm (5 μm particle size) guard, using THF as
eluent at 35 °C. The system was controlled using polystyrene
calibration kits (by RESTEK and Sigma-Fluka); samples were
dissolved in THF at a concentration of 4 mg/mL and filtered
(PTFE filters, 0.45 µm).
Synthesis of propargyl-poly(ε-caprolactone) (Pg-PCL).
Pg-PCL was synthesized as reported in a previous work [25].
Briefly, ε-caprolactone (20 g, 0.175 mol, 5 equiv) was added in
a round flask and heated up to 130 °C. A second yellowish solu-
tion containing propargyl alcohol (2.04 mL, 0.035 mol, 1 equiv)
and tin(II) 2-ethylhexanoate (Sn(Oct)2, 0.0709 g, 0.175 mmol,
0.005 equiv) was prepared, stirred under a nitrogen flow for
20 min, and then added to the ε-caprolactone. The reaction mix-
ture was stirred for 6 h at 130 °C, then stopped by cooling the
flask to room temperature. Purification was carried out by
dissolving the crude in 22 mL of methanol and dropping it in
1320 mL of vigorously stirred water. The resulting precipitate
was isolated by removing the supernatant, dissolved in CH2Cl2
and anhydrified with anhydrous sodium sulphate. Subsequently
it was filtered, and the filtrate was dried under reduced pressure,
obtaining 20 g of final product Pg-PCL as a colorless viscous
oil. Conversionε-CL = 99%; conversionpropargyl alcohol = 96%;
yield = 92%; Mn,NMR = 716 g·mol−1; Mn,GPC = 1345 g·mol−1;
PDI = 1.19 (relative to linear polystyrene). 1H NMR (400 MHz,
CDCl3) δ 4.65 (d, J = 2.4 Hz, 2H, -CH2-CCH), 4.03 (t, J =
6.6 Hz, 2H·(n − 1), -CH2-OC(O)-), 3.61 (t, J = 6.5 Hz, 2H,
-CH2-OH), 2.45 (t, J = 2.4 Hz, 1H, -CH2-CCH), 2.38 – 2.19 (m,
2H·n, -OC(O)-CH2-), 1.70–1.52 (m, 4H·n, -OC(O)-CH2CH2-,
-CH2CH2-OC(O)-), 1.45–1.24 (m, 2H·n, -CH2CH2CH2-).
Synthesis of propargyl-poly(ε-caprolactone)-methacrylate
(Pg-PCL-MA). Pg-PCL-MA was synthesized as reported in a
previous work [25]. Briefly, Pg-PCL (5 g, 0.007 mol, 1 equiv)
was added in a round flask and three cycles of vacuum–nitrogen
were performed. 167 mL of dry toluene were added under
nitrogen flow and the flask was cooled to 0 °C for 30 min. Tri-
ethylamine (1.46 mL, 0.01 mol, 1.5 equiv) and freshly distilled
methacryloyl chloride (1.10 mL, 0.01 mol, 1.5 equiv) were
sequentially added to the reaction mixture. The reaction mix-
ture was stirred at room temperature under dynamic nitrogen at-
mosphere for 15 min and under static nitrogen atmosphere
overnight. The crude was filtered through a celite pad
(h = 6 cm, Φ = 2 cm), washing with toluene, and then the
filtrate was evaporated under reduced pressure. The residue was
taken up in 112.5 mL of CH2Cl2, washed with brine
(3 × 45 mL) and dried over anhydrous sodium sulfate. The sol-
vent was evaporated under vacuum, obtaining 4.14 g of final
product Pg-PCL-MA  as a pale yellow viscous oil .
ConversionOH->OMA = 95%; yield = 75%; Mn,NMR =
740 g·mol−1; Mn,GPC = 1380 g·mol−1; PDI = 1.05 (relative to
linear polystyrene). 1H NMR (400 MHz, CDCl3) δ 6.04 (s, 1H,
H2C-C(CH3)-), 5.50 (s, 1H, H2C-C(CH3)-), 4.63 (d, J = 2.4 Hz,
2H, -CH2-CCH), 4.10 (t, J = 13.1 Hz, 2H, -CH2-O-MA), 4.02
(t, J = 6.7 Hz, 2H·(n − 1), -CH2-OC(O)-), 2.44 (t, J = 2.4 Hz,
1H, -CH2-CCH), 2.38–2.19 (m, 2H·n, -OC(O)-CH2-), 1.89 (s,
3H, H2C-C(CH3)-), 1.75–1.50 (m, 4H·n, -OC(O)-CH2CH2-,
-CH2CH2-OC(O)-), 1.50–1.25 (m, 2H·n, -CH2CH2CH2-).
General procedure (1) for the synthesis of PEGx-PCLy. THF
(inhibitor-free) was degassed under nitrogen for 10 min.
Pg-PCL-MA (y equiv) and poly(ethylene glycol) methyl ether
methacrylate (Mn = 500 Da, x equiv) were added in a Schlenk
tube and three cycles of vacuum–nitrogen were performed. The
catalyst solution was prepared as follows: Copper(I)bromide
(500 mg) was inserted in a Schlenk tube and three cycles of
vacuum–nitrogen were performed. THF (6 mL) and the ligand
1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA,
0.95 mL) were added, obtaining a light green mixture that was
stirred at room temperature under N2 for 10 min. Finally, THF,
the catalyst solution (containing CuBr/HMTETA 1 equiv with
respect to the initiator) and the initiator (1 equiv, ethyl 2-bromo-
2-methylpropionate (1)) were added to the monomers. The reac-
tion mixture was stirred for 6 h at 50 °C under nitrogen atmo-
sphere. The purification was performed by filtering the reaction
mixture through a neutral alumina pad (h = 1.5 cm/mcrude (g),
Φ = 2 cm), washing with CH2Cl2. Then the filtrate was dried
under reduced pressure and the resulting crude was dissolved in
the minimum amount of CH2Cl2 (ca. 1 mg/mL) and dripped in
cold diethyl ether (CH2Cl2/Et2O = 1:60). The mixture was
stored at −20 °C for 3 h and then the resulting precipitate was
isolated by removing the supernatant.
General procedure (2) for the synthesis of A4-PEGx-PCLy.
THF (inhibitor-free) was degassed under nitrogen for 10 min.
Pg-PCL-MA (4y equiv) and poly(ethylene glycol) methyl ether
methacrylate (Mn = 500 Da, 4x equiv) were added in a Schlenk
tube and three cycles of vacuum–nitrogen were performed. The
catalyst solution was prepared as follows: Copper(I)bromide
(500 mg) was inserted in a Schlenk tube and three cycles of
vacuum–nitrogen were performed. THF (6 mL) and the ligand
1,1,4,7,10,10-hexamethyltriethylenetetramine (HMTETA,
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0.95 mL) were added, obtaining a light green mixture that was
stirred at room temperature under N2 for 10 min. Finally, THF,
the catalyst solution (containing CuBr/HMTETA 4 equiv with
respect to the initiator) and the initiator (1 equiv, pentaerythri-
tol tetrakis(2-bromo-isobutyrate, 2) 80 mg/mL in THF) were
added to the monomers. The reaction mixture was stirred for
6 h at 50 °C under nitrogen atmosphere. The purification was
performed by filtering the reaction mixture through a neutral
alumina pad (h = 1.5 cm/mcrude (g), Φ = 2 cm), washing with
CH2Cl2. Then the filtrate was dried under reduced pressure and
the resulting crude was dissolved in the minimum amount of
CH2Cl2 (ca. 1 mg/mL) and dripped in cold diethyl ether
(CH2Cl2/Et2O = 1:60). The mixture was stored at −20 °C for
3 h and then the resulting precipitate was isolated by removing
the supernatant.
Synthesis of PEG9-PCL1. The reaction between Pg-PCL-MA
(245 mg, 0.306 mmol, 1 equiv) and poly(ethylene glycol)
methyl ether methacrylate (1.38 g, 2.751 mmol, 9 equiv) was
performed according to general procedure (1) in THF ([initia-
tor] = 0.068 M), in the presence of CuBr (44 mg, 0.306 mmol,
1 equiv) and HMTETA (0.083 mL, 0.306 mmol, 1 equiv). Ethyl
2-bromo-2-methylpropionate 1 (45 µL, 0,348 mmol, 1 equiv)
was the initiator. 713 mg of final product PEG9-PCL1 were ob-
tained. Conversion = 95%; real PEG = 92%; yield = 62%;
Mn,NMR = 5040 g·mol−1; Mn,GPC = 6090 g·mol−1; PDI = 1.24
(relative to linear polystyrene). 1H NMR (400 MHz, CDCl3) δ
4.67 (d, J = 2.4 Hz, 2H·y, -CH2-CCH), 4.19–3.82 (m, 2H·n·y +
2H·x, PCL: -CH2,PCL-OC(O)-backbone, -CH2-OC(O)-, PEG:
-CH2,PEG-OC(O)-backbone), 3.75–3.50 (m, (4H·(m − 1) +
2H)·x, PEG: -CH2CH2-), 3.37 (s, 3H·x, -OCH3), 2.47 (bs, 1H·y,
-CH2-CCH), 2.40–2.25 (m, (2H·n)·y, PCL: -OC(O)-CH2-),
2.08–1.72 (m, 2H·(y + x), -CH2,backbone-), 1.73–1.53 (m,
(4H·n)·y, PCL: -OC(O)-CH2CH2-, -CH2CH2-OC(O)-),
1.43–1.27 (m, (2H·n)·y, PCL: -CH2CH2CH2-), 1.17–0.69 (m,
3H·(y + x), -CH3,backbone).
Synthesis of PEG8-PCL2. The reaction between Pg-PCL-MA
(517 mg, 0.696 mmol, 2 equiv) and poly(ethylene glycol)
methyl ether methacrylate (1.39 g, 2.784 mmol, 8 equiv) was
performed according to general procedure (1) in THF ([initia-
tor] = 0.068 M), in the presence of CuBr (50 mg, 0.348 mmol,
1 equiv) and HMTETA (0.095 mL, 0.348 mmol, 1 equiv). Ethyl
2-bromo-2-methylpropionate (1, 51 µL, 0.348 mmol, 1 equiv)
was the initiator. 1.48 g of final product PEG8-PCL2 were ob-
tained. Conversion = 91%; real PEG = 82%; yield = 92%;
Mn,NMR = 4990 g·mol−1; Mn,GPC = 6301 g·mol−1; PDI = 1.06
(relative to linear polystyrene). 1H NMR (400 MHz, CDCl3) δ
4.67 (d, J = 2.4 Hz, 2H·y, -CH2-CCH), 4.15–4.0 (m, (2H·n)·y +
2H·x, PCL: -CH2,PCL-OC(O)-backbone, -CH2-OC(O)-, PEG:
-CH2,PEG-OC(O)-backbone), 3.75–3.51 (m, (4H·(m − 1) +
2H)·x, PEG: -CH2CH2-), 3.36 (s, 3H·x, -OCH3), 2.47 (bs, 1H·y,
-CH2-CCH), 2.48–2.28 (m, (2H·n)·y, PCL: -OC(O)-CH2-),
1.95–1.70 (m, 2H·(x + y), -CH2,backbone-), 1.75–1.55 (m,
(4H·n)·y, PCL: -OC(O)-CH2CH2-, -CH2CH2-OC(O)-),
1.45–1.30 (m, (2H·n)·y, PCL: -CH2CH2CH2-), 1.16–0.66 (m,
3H·(x + y), -CH3,backbone).
Synthesis of A4-PEG9-PCL1. The reaction between Pg-PCL-
MA (240 mg, 0.3 mmol, 4 equiv) and poly(ethylene glycol)
methyl ether methacrylate (1.35 g, 2.695 mmol, 36 equiv) was
performed according to general procedure (2) in THF ([initia-
tor] = 0.02 M), in the presence of CuBr (43 mg, 0.3 mmol,
4 equiv) and HMTETA (0.082 mL, 0.3 mmol, 4 equiv). Penta-
erythritol tetrakis(2-bromo-isobutyrate) (2, 55 mg, 0.075 mmol,
1 equiv) was the initiator. 1.24 g of final product A4-PEG9-
PCL1 were obtained. Conversion = 98%; real PEG = 94%;
yield = 85%; Mn,NMR = 20780 g·mol−1; Mn,GPC = 9640
g·mol−1; PDI = 1.11 (relative to linear polystyrene). 1H NMR
(400 MHz, CDCl3) δ 4.66 (d, J = 2.5 Hz, 2H·y, -CH2-CCH),
4.20–3.95 (m, (2H·n)·y + 2H·x, PCL: -CH2,PCL-OC(O)-back-
bone, -CH2-OC(O)-, PEG: -CH2,PEG-OC(O)-backbone),
3.75–3.48 (m, (4H·(m − 1) + 2H)·x, PEG: -CH2CH2-),), 3.36 (s,
3H·x, -OCH3), 2.47 (bs, 1H·y, -CH2-CCH), 2.45–2.20 (m,
(2H·n)·y, PCL: -OC(O)-CH2-), 2.05–1.80 (m, 2H·(y + x),
-CH2,backbone-), 1.73–1.53 (m, (4H·n)·y, PCL: -OC(O)-
CH2CH2-, -CH2CH2-OC(O)-), 1.48–1.30 (m, (2H·n)·y, PCL:
-CH2CH2CH2-), 1.16–0.73 (m, 3H·(y + x), -CH3,backbone).
Synthesis of A4-PEG8-PCL2. The reaction between Pg-PCL-
MA (660 mg, 0.89 mmol, 8 equiv) and poly(ethylene glycol)
methyl ether methacrylate (1.78 g, 3.55 mmol, 32 equiv) was
performed according to general procedure (2) in THF ([initia-
tor] = 0.02 M), in the presence of CuBr (64 mg, 0.44 mmol,
4 equiv) and HMTETA (0.121 mL, 0.44 mmol, 4 equiv). Penta-
erythritol tetrakis(2-bromo-isobutyrate) (2, 81 mg, 0.11 mmol,
1 equiv) was the initiator. 1.5 g of final product A4-PEG8-
PCL2 were obtained. Conversion = 87%; real PEG = 84%;
yield = 74% Mn ,NMR  = 18760 g·mol−1 ;  Mn ,GPC  =
11340 g·mol−1; PDI = 1.06 (relative to linear polystyrene).
1H NMR (400 MHz, CDCl3) δ 4.67 (d, J = 2.4 Hz, 2H·y, -CH2-
CCH), 4.15–3.95 (m, (2H·n)·y + 2H·x, PCL: -CH2,PCL-OC(O)-
backbone, -CH2-OC(O)-, PEG: -CH2,PEG-OC(O)-backbone),
3.75–3.51 (m, (4H·(m − 1) + 2H)·x, PEG: -CH2CH2-), 3.36 (s,
3H·x, -OCH3), 2.47 (bs, 1H·y, -CH2-CCH), 2.49–2.25 (m,
(2H·n)·y, PCL: -OC(O)-CH2-), 2.0–1.75 (m, 2H·(y + x),
-CH2,backbone-), 1.74–1.55 (m, (4H·n)·y, PCL: -OC(O)-
CH2CH2-, -CH2CH2-OC(O)-), 1.45–1.30 (m, (2H·n)·y, PCL:
-CH2CH2CH2-), 1.16–0.66 (m, 3H·(y + x), -CH3,backbone).
General procedure for the CuAAC reaction. In the opti-
mized copper(I)‐catalyzed azide–alkyne cycloaddition
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(CuAAC) procedure, starting materials and reagents were added
to the reaction mixture as solids or as solutions in water or THF.
Water was degassed by bubbling with nitrogen, and THF was
freshly distilled. The reagents were added to the reaction vessel
in the following order: polymer (1 equiv, solid), TBTA
(0.2 equiv, 27 mg/mL in THF), CuSO4·5H2O (0.1 equiv,
21 mg/mL in H2O), sodium ascorbate (0.4 equiv, 67 mg/mL in
H2O) and, after 10 min, 2-azidoethyl α-ᴅ-mannopyranoside 3
(1.5 equiv per each triple bond, 32 mg/mL in H2O). The final
concentration of the alkyne groups was 30 mM in a 1:1 THF/
H2O mixture. The reaction mixture was stirred at room temper-
ature for 3 days, under nitrogen atmosphere and protected from
light, adding 0.25 equiv of sodium ascorbate after 2, 29 and
47 h. The sugar consumption was monitored by TLC (eluent:
CHCl3/MeOH 7:3) and the product formation by 1H NMR.
When intermediates were observed but the azide monovalent
ligand 3 was totally consumed, the latter was added
(0.75 equiv) together with additional 0.25 equiv of sodium
ascorbate. The solvent was evaporated and the crude redis-
solved in water (9 mg/mL) and dialyzed against an excess
(60 times) of water (regenerated cellulose membrane
with MWCO = 3500 Da) for 1 day, changing the water three
times. Final glycopolymers were lyophilized. Final 1H NMR
spectra are reported in Figures S6–S9 (Supporting Information
File 1).
Synthesis of monovalent glycopolymer PEG9-PCL1-Man1.
The reaction between PEG9-PCL1 (150 mg, 0.022 mmolPCL,
1 equivPCL) and (2-azidoethyl)-α-ᴅ-mannopyranoside (3,
8.4 mg, 0.034 mmol, 1.5 equiv) was performed in 1:1 THF/H2O
([alkyne] = 30 mM) according to the general procedure. 124.1
mg of final product PEG9-PCL1-Man1 were obtained. Conver-
sion = 100%; yield = 80%. 1H NMR (400 MHz, CD3OD) δ
8.04 (s, 1H·y, Htriazole), 5.20 (s, 2H·y, -O-CH2-triazole), 4.74
(bs, 1H·y, H1Man), 4.72–4.62 (m, 4H·y, -N-CH2CH2-O-linker),
4.23–4.02 (m, (2H·n)·y + 2H·x, PCL: -CH2,PCL-OC(O)-back-
bone, -CH2-OC(O)-, PEG: -CH2,PEG-OC(O)-backbone),
3.74–3.52 (m, (2H + 4H·(m − 1))·x, PEG: -CH2CH2-), 3.37 (s,
3H·x, -OCH3), 2.45–2.30 (m, (2H·n)·y, PCL: -OC(O)-CH2-),
2.10–1.75 (m, 2H·(y + x), -CH2,backbone-), 1.74–1.55 (m,
(4H·n)·y, PCL: -OC(O)-CH2CH2-, -CH2CH2-OC(O)-),
1.56–1.32 (m, (2H·n)·y, PCL: -CH2CH2CH2-), 1.23–0.76 (m,
3H·(y + x), -CH3,backbone).
Synthesis of divalent glycopolymer PEG8-PCL2-Man2. The
reaction between PEG8-PCL2 (150 mg, 0.05 mmolPCL,
1 equivPCL) and (2-azidoethyl)-α-ᴅ-mannopyranoside (3,
19 mg, 0.075 mmol, 1.5 equiv) was performed in 1:1 THF/H2O
([alkyne] = 30 mM) according to the general procedure. 105 mg
of final product PEG8-PCL2-Man2 were obtained. Conversion
= 100%; yield = 65%; 1H NMR (400 MHz, CD3OD) δ 8.05 (s,
1H·y, Htriazole), 5.20 (s, 2H·y, -O-CH2-triazole), 4.74 (bs, 1H·y,
H1Man), 4.69–4.52 (m, 4H·y, -N-CH2CH2-O-linker), 4.26–4.03
(m, (2H·n)·y + 2H·x, PCL: -CH2,PCL-OC(O)-backbone, -CH2-
OC(O)-, PEG: -CH2,PEG-OC(O)-backbone), 3.80–3.50 (m, (2H
+ 4H·(m − 1))·x, PEG: -CH2CH2-), 3.37 (s, 3H·x, -OCH3),
2.48–2.28 (m, (2H·n)·y, PCL: -OC(O)-CH2-), 2.00–1.75 (m,
2H·(x + y), -CH2,backbone-), 1.75–1.50 (m, (4H·n)·y, PCL:
-OC(O)-CH2CH2-, -CH2CH2-OC(O)-), 1.50–1.30 (m, (2H·n)·y,
PCL: -CH2CH2CH2-), 1.24–0.80 (m, 3H·(x + y), -CH3,backbone).
Synthesis of tetravalent glycopolymer A4-PEG9-PCL1-
Man1. The reaction between A4-PEG9-PCL1 (150 mg,
0.017 mmolPCL, 1 equivPCL) and (2-azidoethyl)-α-ᴅ-manno-
pyranoside (3, 6.3 mg, 0.025 mmol, 1.5 equiv) was performed
in 1:1 THF/H2O ([alkyne] = 30 mM) according to the general
procedure. 117.9 mg of final product A4-PEG9-PCL1-Man1
were obtained. Conversion = 100%; yield = 76%. 1H NMR
(400 MHz, CD3OD) δ 8.04 (s, 1H·y, Htriazole), 5.20 (s, 2H·y,
-O-CH2-triazole), 4.73 (bs, 1H·y, H1Man), 4.67–4.52 (m, 4H·y,
-N-CH2CH2-O-linker), 4.22–4.05 (m, (2H·n)·y + 2H·x, PCL:
-CH2,PCL-OC(O)-backbone, -CH2-OC(O)-, PEG: -CH2,PEG-
OC(O)-backbone), 3.70–3.55 (m, (2H + 4H·(m − 1))·x, PEG:
-CH2CH2-), 3.37 (s, 3H·x, -OCH3), 2.48–2.25 (m, (2H·n)·y,
PCL: -OC(O)-CH2-), 2.05–1.80 (m, 2H·(y + x), -CH2,backbone-),
1.75–1.55 (m, (4H·n)·y, PCL: -OC(O)-CH2CH2-, -CH2CH2-
OC(O)-), 1.50–1.30 (m, (2H·n)·y, PCL: -CH2CH2CH2-),
1.20–0.82 (m, 3H·(y + x), -CH3,backbone).
Synthesis of octavalent glycopolymer A4-PEG8-PCL2-Man2.
The  r eac t ion  be tween  A4-PEG 8 -PCL 2  ( 150  mg ,
0.044 mmolPCL, 1 equivPCL) and (2-azidoethyl)-α-ᴅ-manno-
pyranoside (3, 16.6 mg, 0.067 mmol, 1.5 equiv) was performed
in 1:1 THF/H2O ([alkyne] = 30 mM) according to the general
procedure. 145.2 mg of final product A4-PEG8-PCL2-Man2
were obtained. Conversion = 100%; yield = 90%. 1H NMR
(400 MHz, CD3OD) δ 8.05 (s, 1H·y, HTriazole), 5.20 (s, 2H·y,
-O-CH2-triazole), 4.74 (bs, 1H·y, H1Man), 4.70–4.58 (m, 4H·y,
-N-CH2CH2-O-linker), 4.28–4.03 (m, (2H·n)·y + 2H·x, PCL:
-CH2,PCL-OC(O)-backbone, -CH2-OC(O)-, PEG: -CH2,PEG-
OC(O)-backbone), 3.74–3.55 (m, (2H + 4H·(m − 1))·x, PEG:
-CH2CH2-), 3.37 (s, 3H·x, -OCH3), 2.48–2.30 (m, (2H·n)·y,
PCL: -OC(O)-CH2-), 2.20–1.75 (m, 2H·(y + x), -CH2,backbone-),
1.73–1.60 (m, (4H·n)·y, PCL: -OC(O)-CH2CH2-, -CH2CH2-
OC(O)-), 1.52–1.31 (m, (2H·n)·y, PCL: -CH2CH2CH2-),
1.25–0.77 (m, 3H·(y + x), -CH3,backbone).
Particle size measurements by DLS
DLS analyses of polymers (1 mg/mL, filtered solutions with
PTFE 0.45 µm filters) were performed using a Malvern Instru-
ment Zetasizer Nano ZS instrument equipped with a 4 mW
He–Ne laser operating at λ = 634 nm. Particle size distribution
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by scattering intensity (%) was determined by the CONTIN
algorithm, as provided by the Zetasizer software (Malvern,
UK). Particle size distribution by volume (%) was calculated
from the scattering intensity distributions by the Zetasizer soft-
ware, by setting the refractive index of the material
R.I. = 1.465, which corresponds nearly to the refractive indices
of poly(ethylene glycol) methacrylate Mn  = 500 Da
(R.I. = 1.467) as well as of the ε-caprolactone repeating units
(R.I. = 1.463), as reported by the supplier (Sigma Aldrich).
Transmission electron microscopy
TEM images were acquired with a DeLong America LVEM5
microscope, equipped with a field-emission gun and operating
at 5 kV. TEM samples were prepared by dropping 10 µL of
sample (10 mg/mL in water) on a copper grid (400 mesh)
placed on filter paper. The grid was left to dry overnight for
evaporating the solvent.
Turbidimetric assay
This assay was performed in filtered (PTFE, 0.2 μm) HEPES-
buffered saline (HBS), containing 10 mM HEPES, 150 mM
NaCl and 1 mM CaCl2 at pH 7.4, according to a procedure
already reported in the literature [38]. The stock solution of
Con A (6 μM with respect to the tetramer, MW = 104000 Da)
was freshly prepared. Turbidity measurements were performed
by adding 100 µL of the glycopolymer solution in HBS buffer
to 500 µL of stock Con A solution. Final concentrations were
50 µM per mannose residue and 20 µM per Con A binding site,
corresponding to a ratio Con A binding site/mannose = 1:2.5.
The Con A-glycopolymer solution was vigorously stirred for
11 s using a micropipette and then placed in a Jasco V-630
UV–vis spectrometer at 30 °C, using semi-micro disposable
cuvettes (optical PS, 2.5 mL volume, 1 cm path length). Optical
Density (OD) data were recorded at 420 nm every 12 s for
10 min. t1/2 was calculated as the time to reach half of the
maximum optical density in the OD curve. The first three points
of the curve was fit with a straight line and its slope was used to
determine the initial rate of Con A aggregation k.
Supporting Information
Supporting Information File 1
Additional experimental data.
[https://www.beilstein-journals.org/bjnano/content/
supplementary/2190-4286-10-212-S1.pdf]
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